Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_6033_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Preface
- •Contents
- •2.1 Introduction
- •2.2 Lumbar Anatomy
- •2.2.1 Vertebra
- •2.2.2 Intervertebral Discs
- •1: History and Rationale for the Minimally Invasive Lateral Approach
- •1.1 Introduction
- •1.2 Historical Approaches to the Lumbar Spine
- •1.4 Validation of the Technique
- •References
- •2: Biomechanics of Lateral Spinal Reconstruction
- •2.2.3 Facets
- •2.2.4 Muscles and Ligaments
- •2.3.1 The Neutral Zone
- •2.3.2 Bending Moments and Load Carrying
- •2.3.3 Lumbar Lordosis
- •2.4 Biomechanics of Lumbar Pathology
- •2.4.1 Lumbar Surgery
- •2.5 Lateral Lumbar Fixation
- •References
- •3.1 Goals of Minimally Invasive Spine Surgery
- •3.2.1 Blood Loss
- •3.2.2 Decreased Infection Rates
- •3.2.4 Pain Control and Recovery
- •References
- •4: Costs and Economic Implications
- •4.1 Introduction
- •4.2 The Costs of Spine Surgery
- •4.3 Comparative Effectiveness of the MIS Lateral Approach
- •4.4 Cost-Effectiveness of the MIS Lateral Approach
- •4.5 Future Directions
- •References
- •5: Workup and Diagnostic Testing
- •5.1 Introduction
- •5.2 Patient History
- •5.3 Physical Examination
- •5.4 Adjunctive Tests
- •5.5 Preoperative Evaluation of the Pain Generator
- •5.6 Radiographic Studies
- •5.7 Summary
- •References
- •6: Literature Evidence of the MIS Lateral Approach
- •6.1 Adult Spinal Deformity
- •6.1.1 Studies
- •6.1.2 Treatment Characteristics
- •6.1.3 Clinical Outcomes
- •6.1.4 Fusion
- •6.1.5 Complications
- •6.1.7 Conclusion
- •6.2 Degenerative
- •6.2.1 Studies
- •6.2.3 Operative Time
- •6.2.4 Length of Stay
- •6.2.5 Clinical Outcomes
- •6.2.6 Fusion
- •6.2.7 Complications
- •References
- •7: Selecting the Proper Patient for Lumbar Lateral Interbody Fusion and Minimally Invasive Spinal Deformity Surgery
- •7.1 Indications for LLIF
- •7.2 The MISDEF Algorithm
- •References
- •8: Positioning and Safety
- •8.1 Introduction
- •8.2 Positioning the Patient
- •8.3.1 Pressure Ulcers
- •8.3.2 Peripheral Nerve Injury
- •8.3.3 Rhabdomyolysis
- •8.3.4 Postoperative Visual Loss
- •References
- •9: Intraoperative Electrophysiologic Monitoring
- •9.1 Introduction
- •9.2 Anatomic Considerations
- •9.3.2 Somatosensory Evoked Potentials (SSEP)
- •9.3.3 Spontaneous Electromyography (spEMG)
- •9.3.4 Triggered Electromyography (trEMG)
- •9.4 Patient Preparation and Anesthesia Requirements
- •9.6 Ongoing Monitoring
- •References
- •10: Motor-Based Monitoring During Minimally Invasive Lateral Spine Surgery
- •10.1 Introduction
- •10.3 Motor-Evoked Potentials
- •10.4 Electromyography
- •10.4.1 EMG Limitations
- •10.5 Mechanomyography
- •References
- •11: Frameless Navigation
- •11.1 Introduction
- •11.2 Technique
- •11.2.1 Positioning
- •11.2.2 Image Acquisition and Registration to CaSN
- •11.2.3 Surgical Approach and Cage Placement with CaSN
- •References
- •12.7 Retraction
- •12.8 Shallow Docking
- •12.9 Oblique Approach
- •References
- •12: Techniques for Avoiding Psoas Muscle and Lumbosacral Plexus Injury
- •12.1 Introduction
- •12.2 Anatomy
- •12.5 Retroperitoneal Dissection
- •12.6 Electromyography
- •13: Single Versus Dual Incisions for Lateral Retroperitoneal Approach
- •13.1 Single Incision
- •13.1.1 Surgical Technique
- •13.2 Dual Incisions
- •13.2.1 Surgical Technique [1]
- •13.2.2 Advantages and Disadvantages
- •References
- •14: Lateral Transpsoas Retractor Technology
- •14.1 Introduction
- •14.2 MaXcess® (NuVasive, Inc.)
- •14.3 Mars® 3V (Globus, Inc.)
- •14.5 Pipeline® (Depuy Synthes, Inc.)
- •14.6 Oracle® (Depuy Synthes, Inc.)
- •14.7 Aira® 3 (Stryker, Inc.)
- •14.8 Ravine® 3 (K2M, Inc.)
- •14.9 Veo® (Baxano, Inc.) [6]
- •References
- •15: Anterior to Psoas (ATP) Fusion of the Lumbar Spine
- •15.1 Introduction
- •15.2 Indications
- •15.3 Contraindications
- •15.4 Equipment
- •15.5 Surgical Technique
- •15.5.1 Patient Positioning
- •15.5.2 Incision
- •15.5.3 Exposure of the Disc
- •15.5.4 Discectomy and Endplate Preparation
- •15.5.4.1 ALL Release
- •15.5.5 Cage and Plate Insertion
- •15.5.5.1 L5/S1
- •15.6 Discussion
- •15.6.1 History
- •15.6.2 Cages
- •15.6.2.1 Clinical Results
- •15.6.3 Retractors
- •15.6.3.1 Neuromonitoring
- •15.6.4 Psoas Retraction
- •15.6.5 Levels
- •15.6.6 Vascular Injuries
- •15.6.7 Nerve Injuries
- •15.7 ALL Section
- •References
- •16: Thoracic MIS Retropleural Access
- •16.1 Introduction
- •16.2 Anterior-Based Approaches
- •16.3 Posterior-Based Approaches
- •16.4 Lateral-Based Approaches
- •16.5 Surgical Technique and Anatomic Considerations
- •16.5.1 Preoperative Planning
- •16.5.2 Preparation and Patient Positioning
- •16.5.3 Surgical Approach
- •16.5.4 Postoperative Care
- •16.6 Outcomes Using a Minimally Invasive Anterolateral Approach
- •16.7 Advantages of the Minimally Invasive Lateral Approach
- •16.8 Limitations of the Minimally Invasive Lateral Approach
- •16.9 Summary
- •References
- •17: Psoas Muscle Management
- •17.1 Introduction
- •17.3 Transpsoas Versus ATP
- •17.4 Traversing the Psoas Major
- •References
- •18: The Extreme Lateral Minimally Invasive Approach to Pure Degenerative Lumbar Disk Disease
- •18.1 Introduction
- •18.2 The Rome Experience
- •18.2.1 Surgical Technique
- •18.3 Results
- •18.3.1 Demonstrative Cases
- •18.3.1.1 Case 1
- •18.3.1.2 Case 2
- •18.3.1.3 Case 3
- •18.4 Discussion
- •References
- •19: Lateral Approach for Spondylolisthesis
- •19.1 Introduction
- •19.2 Treatment
- •19.3 Surgical Technique
- •19.4 Outcomes
- •19.5 Complications
- •References
- •20: Lateral Lumbar Interbody Fusion (LLIF) for the Treatment of Adult Spinal Deformity (ASD)
- •20.1 Introduction
- •20.2 MIS Treatment Algorithm
- •20.3 Surgical Technique
- •20.3.1 Patient and Bed Positioning
- •20.3.2 Fluoroscopic Imaging
- •20.3.3 Access to the Psoas
- •20.3.4 Transpsoas Approach and Retractor Docking
- •20.3.5 Preparing the Disk Space
- •20.3.6 Maximizing Correction
- •20.3.7 Approach Through the Concavity vs. Convexity
- •20.3.8 Sequence of LLIF Instrumentation
- •20.3.9 Wound Closure
- •20.4 Outcomes
- •References
- •21: Neoplasia
- •21.1 Introduction
- •21.2 Clinical Features
- •21.3 Diagnosis
- •21.4 Primary Vertebral Tumor
- •21.4.1 Aneurysmal Bone Cyst
- •21.4.2 Hemangioma
- •21.4.3 Osteosarcoma
- •21.4.4 Giant Cell Tumor
- •21.4.6 Meningioma
- •21.4.7 Nerve Sheath Tumor
- •21.5 Surgical Treatment for Primary and Metastatic Spine Tumors
- •21.5.1 Open Surgery
- •21.5.2 MIS Lateral Approach
- •References
- •22: Minimally Invasive Lateral Spine Surgery in Trauma
- •22.1 Introduction
- •22.3 Indications for the Anterior Approach
- •22.4 Complications Associated with the Open Anterior and Posterior Approaches
- •22.6 Lateral MISS Techniques
- •References
- •23: Lateral MIS Surgery for Spinal Column Infections
- •23.1 Introduction
- •23.2.1.1 Indications
- •23.2.1.2 Contraindication
- •23.2.2 Technique
- •23.2.2.1 Preoperative Preparation
- •23.2.2.2 Operative Procedure
- •23.2.2.3 Postoperative Treatment
- •23.3 Clinical Outcomes
- •23.4 Complications
- •23.4.1 Approach-Related Complications
- •23.4.2 Instrumentation-Related Complications
- •23.4.3 Infection-Related Complications
- •23.5 Case Studies
- •23.5.1 Case 1
- •23.5.2 Case 2
- •Further Reading
- •25: Lateral Lumbar Interbody Fusion: A Review of the Current Clinical Outcomes of Different Supplemental Fixation Techniques
- •25.1 Introduction
- •25.2.1 Case Example
- •25.3 Interspinous Fusion
- •25.3.1 Case Example
- •25.4 Integrated Fixation Fusion
- •25.5 Simultaneous Combined Anterior and Posterior Fusion
- •References
- •26: Anterolateral Fixation in LLIF
- •26.1 Introduction
- •26.3 When? The Indications for Supplemental Fixation
- •26.3.1 Reduced Bone Density
- •26.3.2 Facet Arthropathy
- •26.3.3 Deformity
- •26.3.4 Instability
- •26.3.5 Pars Defects
- •26.3.6 Cage Width and Levels
- •26.3.7 Adjacent Segment Disease
- •26.3.8 Previous Surgery
- •26.4.1 Lateral Fixation
- •26.4.2 Posterior Fixation
- •26.4.3 Combination Lateral and Posterior Fixation
- •References
- •27: Anterior Column Realignment
- •27.1 Introduction
- •27.2 Applications
- •27.3 Regional Anatomy
- •27.4 Surgical Technique
- •27.5 Potential Pitfalls
- •27.6 Complications
- •References
- •28: Subsidence in LLIF
- •28.1 Introduction
- •28.3 Rates
- •28.4 Risk Factors
- •28.4.1 Caudal Endplate
- •28.4.2 Level
- •28.4.3 Bone Quality
- •28.4.4 Cage Size
- •28.4.5 Bone Morphogenetic Protein
- •28.6 Prevention/Recommendations
- •28.6.1 Standalone Cages/Supplemental Posterior Instrumentation
- •References
- •29: Osteobiologics
- •29.1 Introduction
- •29.2 Autografts
- •29.3 Allograft Bone
- •29.3.1 Demineralized Bone Matrix
- •29.4 Ceramics
- •29.5 Bone Morphogenetic Proteins
- •29.6 Bone Marrow Aspirate (BMA)
- •29.7 Platelet Gels
- •29.8 Summary
- •References
- •30: Indirect Decompression
- •30.1 Lumbar Stenosis
- •30.2 Lateral Interbody Fusion
- •References
- •31: Approaching a Deformity from the Concavity Versus Convexity
- •31.1 Introduction
- •31.2 Concavity Approach
- •31.3 Convexity Approach
- •31.4 The Importance of L4/L5
- •31.5 Additional Considerations
- •References
- •32: Awake Lateral Lumbar Fusion
- •33: Managing and Preventing Vascular Complications
- •33.1 Introduction
- •33.3 Incidence of Vascular Complications in Lumbar Spine Surgery
- •33.3.1 Posterior Approach
- •33.3.2 Anterior Conventional Approach
- •33.3.3 Lateral or Extreme Lateral Retroperitoneal Transpsoas Approach
- •33.4 Surgical Features in Lateral Retroperitoneal Transpsoas Interbody Fusion
- •33.5 Preventive Measures of Vascular Complications in Anterior Lumbar Spine Surgery
- •33.5.1 Preoperative Period
- •33.5.2 Operative Period
- •33.5.3 Postoperative Period
- •33.6 Management of Vascular Injuries
- •33.6.1 Venous Injury
- •33.6.2 Arterial Injury
- •References
- •34: Managing and Preventing Soft Tissue Complications
- •34.1 Introduction
- •34.3 Retroperitoneal Injuries
- •34.4 Management of Complications
- •34.5 Prevention of Complications
- •References
- •35: Ileus and Gastrointestinal Complications
- •35.2.1 Neural
- •35.2.3 Pharmacologic
- •35.6 Fiscal Consequences of POI
- •References
- •36: Lumbar Plexus Injury: Lateral MIS Spinal Fusion
- •36.1 Introduction
- •36.2 Sensory Complications
- •36.2.2 Ilioinguinal Nerve (L1): SDZ1
- •36.2.4 Lateral Cutaneous Nerve (L2, L3): SDZ2
- •36.3 Motor Complications
- •36.3.1 Femoral Nerve (Dorsal L2–L4)
- •36.3.2 Obturator Nerve (Ventral L2–L4) and Lumbosacral Trunk (L4, L5)
- •References
- •Index

356
Index
Anterior column realignment (ACR) technique , 56, 124
for adult spinal deformity correction , 265
applications , 265–266
complications , 271
pitfalls , 269
regional anatomy , 266–268
surgical technique , 267–270
Anterior longitudinal ligament (ALL) , 18, 19,
106, 115, 117, 118, 124, 171, 238,
262, 264, 265, 267, 268, 271, 334
Anterior lumbar disc replacement (ALDR) , 341
Anterior lumbar interbody fusion (ALIF) ,
3, 18, 158, 164, 246, 259
Anterior +/− posterior longitudinal ligaments
(ALL/PLL) , 259
Anterior superior iliac spine (ASIS) , 81, 351
Anterior to psoas (ATP) fusion , 111
ALL sectioning , 124
cages , 119–121
contraindications , 112
equipment , 112
history , 119
indications , 112
levels for , 122–124
nerve injuries , 124
psoas retraction , 122
retractors , 121–122
surgical technique
cage and plate insertion , 117–119
discectomy and endplate preparation ,
116–117
disc exposure , 113–116
incision , 113
patient positioning , 112–113
vascular injuries , 124
Arterial injury , 325–326, 334
Arterial thrombosis , 326
ASD . See Adjacent segment disease (ASD);
Adult spinal deformity (ASD)
Autografts bone
history , 279
ICBG grafts , 280
mechanical stability , 280
osteoconduction , 280
osteogenic , 280
osteoinduction , 279–280
Awake lateral lumbar fusion, local anesthesia
case study
percutaneous fl uoroscopic-guided needle
placement , 307
port placement docked onto surface of disc
over dilator , 308
postoperative AP and lateral radiograph of
single-level percutaneous , 313
preoperative MRI , 307
4-year follow-up radiographs in pain-free
patient , 315
guide wire placement , 305
three-level fusions , 316
titration of anesthesia , 305
B
Back pain , 17, 18, 43, 123, 152, 163, 236, 245, 289, 294
Bilateral pedicle screw-rod construct , 263
Bilateral posterior pedicle screw fi xation , 28
Blunt intradiscal spreader , 182, 184
Bone densitometry (DEXA) scan , 236
Bone graft
allografts , 279
cortical , 280–281
corticocancellous grafts , 281
DBM , 281–282
freeze-dried , 280
fresh-frozen , 280
manufacture , 281
musculoskeletal , 281
autografts , 279
history , 279
ICBG grafts , 280
mechanical stability , 280
osteoconduction , 280
osteogenic , 280
osteoinduction , 279–280
BMA , 284, 286
BMPs , 283–284
ceramics , 282–283
complications , 284–285
infl ammatory phase , 279
non-autologous grafts , 279
platelet gels , 284
remodeling phase , 279
reparative phase , 279
role , 279
Bone marrow aspirate (BMA) graft , 284, 286
Bone mineral density (BMD) , 13, 129, 276
Bone morphogenetic proteins (BMPs) ,
279–280, 283–285
Brachial plexus injury , 65
Burst fractures , 16, 210, 215–217, 219, 220
C
CaSN
image acquisition and registration to , 82
patient positioning , 81–82
surgical approach and cage placement with , 82–87
Catheter thrombectomy , 326
Ceramics , 282–283
Cerebrospinal fl uid (CSF) leak , 193, 235, 236
Chewing gum , 343
Chronic back pain , 297
Chronic opioid-induced constipation , 343
Coagulation studies (PT/PTT) , 32
Cobb elevator , 115, 119, 182, 183
C o fl ex-F
®
stabilization , 253–254
Colostomy , 330, 334
Complete blood count (CBC) , 32
Computed tomography (CT) scan , 33, 121–123,
144, 159, 166, 167, 188, 192, 194, 231,
232, 236, 238, 270, 274, 294, 305, 335, 336
aneurysmal bone cyst , 204

Index
357
hemangiomas , 205
MM/plasmacytoma , 206
osteosarcoma , 205
spinal tumors , 202, 203
thoracic spine psammomatous
meningioma , 202, 203
Continuous epidural analgesia (CEA) , 344
Coronal Cobb angle (CCA) , 194–196
Corpectomy , 61, 209–211, 216, 217, 219, 220, 222
Cortical screws , 263
Corticotrophin-releasing factor (CRH) , 340
Cost-effective analyses , 29, 30
Costotransversectomy , 208
C T . See Computed tomography (CT) scan
™
retractor , 114–116
Curvy
D
Degenerative disc disease (DDD) , 17, 245
clinical outcomes , 40, 42, 43
complications and side effects , 39, 42–45
fusion , 43
length of hospital stay , 40
neural defi cits , 45–46
operative time , 39
study characteristics , 39, 40
treatment , 143
case studies , 146–149
characteristics , 39, 41
clinico-neurological evaluations , 144
complications , 145, 146
direct visualization , 150–152
epidemiological and clinical data , 145, 146
evaluation tests , 145, 146
preoperative radiological evaluation , 144
surgical technique , 144–145
XLIF for , 150
Delayed cage subsidence (DCS) , 274
Demineralized bone matrix (DBM) , 280
Dexamethasone , 181
Dexmedetomidine hydrochloride injection , 305
Diffuse idiopathic skeletal hyperostosis
(DISH) , 269
Direct lateral lumbar interbody fusion (DLIF) ,
27, 73, 157, 226, 329
Diskectomy , 53, 138, 139, 145, 151, 211, 217, 218
Droperidol , 305
Dual incisions technique , 101–102
Duodenal ulcer , 341
Dysesthesias , 38, 193–194, 302, 330
Electrophysiological technology , 335
En bloc resection technique , 204–206, 208, 209
en-phos lateral approach , 137
Epidural analgesia , 344
Esophagitis , 341
Estimated blood loss (EBL) , 247
Ethambutol , 231
Ewing’s sarcoma , 201, 209
Extreme lateral interbody fusion (XLIF
®
) ,
27, 35, 73, 157, 211, 226, 329
adult spinal deformity
(see Adult spinal deformity )
degenerative (see Degenerative disc disease (DDD) )
F
Facet , 13
arthropathy , 260
capsule , 18
joint spondylosis , 18
screws , 263
Facetectomy , 208
™
Fibrillar
, 325
Fluoroscopy , 31, 63, 73, 81, 83, 84, 94, 112,
113, 129, 131, 145, 157, 174, 176,
227, 229, 237, 263, 269
Food and Drug Administration (FDA) ,
249, 250, 253, 284, 285
Force vector , 15, 16, 18
Fracture dislocation , 216, 217
G
Gabapentin , 181
Gastroesophageal refl ux disease , 342
G clamp blade , 115–117, 122, 124
®
Gelfoam
, 325
Genitofemoral (GF) nerve ,
67, 114, 124, 178, 179
Giant cell tumor (GCT) , 201, 205–206
Groin numbness , 348
H
Health-related quality of life (HRQOL) , 164
Hemangioma , 201, 202, 204, 205, 210, 211
Hip fl exion , 32, 77, 90, 136, 139, 145, 159, 173, 238
Hip numbness , 347, 348
Hydroxyapatite , 282
E
Early cage subsidence (ECS) , 274
Electrocardiograms (ECG) , 32
Electrocautery , 139
Electromyelography (EMG) , 236, 237
Electromyogram (EMG) , 38
Electromyography (EMG) monitoring ,
32, 74–76, 138, 139, 145, 179, 334
I
Idiopathic scoliosis (IS) , 163
Iliac crest bone graft (ICBG) , 280–282, 284, 285
Iliohypogastric nerves , 113
Instantaneous axis of rotation (IAR) , 15–17
Insulin growth factor 1 (IGF-1) , 281
Integrated fi xation cages (IFCs) , 254–255
International Spine Study Group (ISSG) , 195
Interspinous clamps , 262, 263

358
Index
Interspinous fusion devices (IFDs)
advantage , 248
biomechanical studies , 253
case examples , 253–254
construct stability , 248
indications and implantation techniques , 249, 253
partial list by FDA , 249–252
Interspinous process devices (IPDs) , 248
Intralesional resection , 204
Intraoperative neuromonitoring (IONM) , 67, 71–72
anesthesia requirements , 70
MEP , 68
neural mapping technique , 70–71
ongoing monitoring , 71
patient preparation , 70
spEMG , 69
SSEP , 68–69
trEMG , 69–70
Intravenous Tylenol , 343
Ipsilateral iliopsoas weakness , 271
Isoniazid , 227, 228, 231
J
Japanese Orthopedic Association Assessment
(JOA) , 229
K
Knee extension weakness , 32
Kyphoplasty , 205, 206, 209
L
Laminectomy , 3, 17, 19, 58, 122, 127, 128, 145, 151,
159, 207, 237, 247, 262, 289, 290, 324
Lateral endoscopic transpsoas retroperitoneal approach
(LETRA) , 4
Lateral femoral cutaneous nerve (LFCN) , 38
Lateral fl uoroscopy , 113, 267, 270
Lateral interbody fusion (LIF) , 23, 290
disc height restoration , 290
indirect decompression
benefi ts , 294
interspinous spacers development , 290–291
LIF , 291–292
X-STOP vs. nonoperative care , 290
postoperative sagittal MRI , 290, 292–293
preoperative sagittal MRI , 290–291, 294
Lateral lumbar fi xation , 19–20
Lateral lumbar interbody fusion (LLIF) , 27, 73, 329
anterior interbody fusion procedure , 259
avoiding psoas muscle and lumbosacral plexus injury
anatomy , 89–90
complications , 89
electromyography , 93
oblique approach , 94–95
preoperative planning and setup , 92–93
retraction , 94
retroperitoneal dissection , 93
shallow docking , 94
symptoms and relevance , 90–92
bone graft biomechanics , 245
combined ALIF and PLIF , 255
complications , 245
defi nition , 5–6
neuromonitoring practices , 246
patient selection
indications , 53
MISDEF algorithm , 53–58
spondylolisthesis , 157–160
subsidence
cage development , 273
classifi cation , 273–274
effect on clinical outcomes , 276
factors , 273
fusion rates , 277
prevention/recommendations , 277
rates , 274
risk factors , 274–276
supplemental fi xation
benefi ts , 259
IFDs (see Interspinous fusion devices (IFDs) )
indications , 260–262
integrated fi xation fusion , 254–255
options , 262–264
pedicle screw , 246–249
reasons for , 259
surgery for intractable LBP syndromes , 245
Lateral retroperitoneal approach
advantages , 102
disadvantages , 102
dual incisions technique , 101–102
single incision technique , 101
Lateral transpsoas retractor technology , 103
MaXcess
NIM-Eclipse
Oracle
Pipeline
Quadrant
Ravine
®
retractor ( see MaXcess ® retractor )
®
neuromonitoring , 107
®
(Depuy Synthes, Inc.) , 107
®
(Depuy Synthes, Inc.) , 107
®
(Medtronic Sofamor Danek, Inc.) , 107
®
3 (K2M, Inc.) , 108
RAVINE retractor , 108
Supra-psoas (Shallow) docking , 109
®
(Baxano, Inc.) , 108–109
Veo
L B P . See Low-back pain (LBP)
L4/5 disc , 111, 113, 115, 116, 120, 122, 124
Length of stay (LOS) , 341
Lidocaine , 305
Ligamentotaxis , 3, 7, 289, 290
LLIF . See Lateral lumbar interbody fusion (LLIF)
Low-back pain (LBP) , 3
among USA populations , 255
by degenerative disc disease , 17
pathophysiology , 245
visual analogue scale , 28
L5/S1 disc , 112, 118–119
Lumbar fracture , 3, 215
Lumbar fusion , 56, 135, 235, 280, 282, 340, 341
Lumbar plexus injury, lateral trans-psoas approach
anatomy , 347, 349
complications , 347–348
lateral perspective , 347–348
motor complications
femoral nerve (dorsal L2–L4) , 352

Index
359
lumbosacral trunk (L4, L5) , 352
obturator nerve (ventral L2–L4) , 352
self-limited within time course , 347
sensory complications , 347
genitofemoral nerve (L1, L2) , 351
iliohypogastric nerve (T12, L1) , 350–351
ilioinguinal nerve (L1) , 351
lateral cutaneous nerve (L2, L3) , 351
SDZ classifi cation system , 349
stretch injury , 348
Lumbar spinal stenosis (LSS)
complications , 290
neurogenic claudication , 289
nonoperative pain management , 289
surgical intervention , 290
symptoms , 289
Lumbar spine
anatomy , 11–12
elements , 11–12
facets , 13
intervertebral discs , 12–13
muscles and ligaments , 13
vertebra , 12
biomechanics , 19–20
geometry and stability , 13–14
bending moments and load carrying , 14–16
lumbar lordosis , 16–17
neutral zone , 14
lateral access surgery
advancement , 7
ALIF , 3
applications , 7
comparison of PLIF, LLIF and TLIF , 4
60-degree approach , 4, 5
development , 4–6
future steps , 7
validation of , 6–7
minimally invasive lateral approaches
adjunctive tests , 32
patient history , 31–32
physical examination of patient , 32
preoperative evaluation , 32
radiographic evaluation , 32–33
pathology
degenerative disc disease , 17
lumbar stenosis , 17–18
lumbar surgery , 18–19
spondylolithesis , 18
Lumbar tuberculosis , 229
Lyrica , 181
M
Magnetic resonance imaging (MRI) , 33, 202–203
GCTs , 206
hemangiomas , 205
lumbar spine neurofi broma , 207, 208
meningioma , 206, 207
osteosarcoma , 205
sacrum aneurysmal bone cyst , 204
Magnetic resonance neurography (MRN) , 33, 167, 168
®
3V (Globus, Inc.) , 107
Mars
™
MAST Quadrant
MaXcess
®
lateral retractor system , 121
retractor , 132
access , 106
blades , 106
evoked-EMG stimulation in , 103–104
lateral illustration , 105
mounting , 106
neuromonitoring , 106–107
photograph , 103, 104
primary feature , 104–105
in XLIF approach , 103
anterior illustration , 105
surgeon’s point of view , 105, 106
Mechanomyography (MMG) neuromonitoring , 74, 76,
179
™
Medtronic OLIF25
technique , 111, 113, 118–120
Mesenchymal stem cell (MSC) , 284
Methylnaltrexone , 343
Mickey Mouse sign , 302
Minimally invasive lateral transpsoas approach to the
lumbar spine for interbody fusion (MI-LIF) ,
73, 76–77
Minimally invasive spinal deformity surgery (MISDEF)
algorithm , 169–170
adult spinal deformity
back and leg pain patient , 56–58
dominant back pain , 55–57
limitations , 57
neurogenic claudication/radiculopathy patient , 55,
56
open vs. minimally invasive techniques , 54
reliability , 56–57
Minimally invasive spine (MIS) surgery technique , 3, 329
advancement , 7
ALIF , 3
applications , 7
comparison of PLIF, LLIF and TLIF , 4
complications , 27
costs and economic implications
cost-effectiveness , 28–29
future directions , 29–30
for spine surgery , 27–28
XLIF/DLIF/LLIF vs. PLIF/TLIF , 28
60-degree approach , 4, 5
development , 4–6
future steps , 7
goals , 23
lumbar spine , 3–4
adjunctive tests , 32
patient history , 31–32
physical examination of patient , 32
preoperative evaluation , 32
radiographic evaluation , 32–33
physiological benefi ts
decreased infection rates , 24
pain control and recovery , 24
reduced blood loss , 23–24
reduced soft tissue disruption , 24
validation of , 6–7
Mini-open technique , 4, 23, 239
MiSLAT (Mummaneni, Wang, Silva, Lenke, Amin, Tu)
algorithm , 168–170

360
Index
MIS Lateral System , 73
Motor-based monitoring
electromyography , 74–76
MEPs , 74
MMG , 74, 76
neurophysiologic monitoring , 74
Motor evoked potentials (MEPs) , 68, 74, 180
Multilevel lateral interbody fusions , 265
Multiple myeloma (MM) , 206
Mycobacterium tuberculosis , 228
N
Nasogastric tube , 341
Neostigmine , 344
Nerve sheath tumor (NST) , 207–208
Neuroforamen , 289, 290, 294
Neurogenic claudication , 163, 236, 289
Neuromonitoring , 5, 31, 46, 67, 71, 106–109, 111, 112,
120, 122, 138, 139, 144, 145, 152, 158, 179,
229, 246, 335, 336, 347
®
NIM-Eclipse
neuromonitoring , 107
Nonsteroidal anti-infl ammatories , 343
O
O-arm fl uoroscopy , 82
O-arm Surgical Imaging System , 81
Oblique lumbar interbody fusion (OLIF) , 158
Ogilvie’s syndrome , 343
™
OLIF51
method , 111, 118
Open posterior approaches , 164
Open thoracotomy technique , 127, 128
Opioids , 343
®
(Depuy Synthes, Inc.) , 107
Oracle
Osteoconduction , 279, 280
Osteoinduction , 279, 281
Osteosarcoma , 201, 204, 205, 209–211
Oswestry disability index (ODI) ,
28, 143, 195, 211, 229, 230, 246
P
Pain , 302
back , 17, 18, 43, 123, 152, 163, 289, 294
groin , 348, 351
hip , 348
leg , 7, 43, 54, 56–58, 150, 155, 195,
230, 247, 253, 290, 294, 348
low back (see Low-back pain (LBP) )
radicular , 89, 121, 150, 348
Panel on Cost-Effectiveness in Health and
Medicine , 30
Paresthesias , 38, 45, 90, 289, 348
Patient-controlled analgesia (PCA) , 344
Patient positioning , 61, 65
anesthetized and intubated , 61
arms and head placement , 62, 63
avoiding iatrogenic injuries , 61
axillary roll in lateral decubitus position , 62, 63
bed placement , 63
chest and abdomen in lateral position , 62
complications associated with
peripheral nerve injury , 64–65
postoperative visual loss , 65
pressure ulcers , 64
rhabdomyolysis , 65
fl uoroscopy examination , 63
gel pad placement , 62
in lateral decubitus position , 61–62
table placement , 63
Velcro safety straps , 62
Pedicle screw supplemental fi xation , 246–249
Pedicle subtraction osteotomy (PSO) , 265
Percutaneous pedicle screw (PPS) fi xation , 193
Percutaneous XLIF technique , 138
Peripheral nerve injury , 61, 64–65
®
Pipeline
(Depuy Synthes, Inc.) , 107
Plasmacytoma , 201, 204, 206, 210, 211
Platelet-derived growth factor (PDGF) , 284
Platelet gels , 284
PLIF . See Posterior lumbar interbody fusion (PLIF)
Polyetheretherketone (PEEK) , 7, 245
Ponte osteotomy , 266
Positron emission tomography (PET) , 203
Posterior lumbar interbody fusion (PLIF) ,
4, 18, 23, 39, 158, 164, 235, 245–246, 284
Postoperative ileus (POI)
cost of , 344
defi nition , 339
incidence and GI risk factors
after surgery , 341–342
in spinal surgery , 340–341
management
alvimopan , 343
chewing gum , 343
epidural analgesia , 344
invasive treatments , 343
methylnaltrexone , 343
neostigmine , 344
preoperative bowel preparation , 344
mechanisms
on bowel mobility , 339
infl ammatory , 340
neural , 339–340
pharmacologic , 340
Postoperative visual loss , 65
Post-op pulmonary embolus (PE) , 193
Pressure ulcers , 64
Proximal junctional kyphosis (PJK) ,
24, 53, 54, 194, 235, 236, 238
Psoas major muscle
anatomy , 135–137
complications , 138
transpsoas vs. ATP , 137–138
transversing , 138–139
Psoas weakness , 348
Pyrazinamide , 227, 228, 231
Q
Quadrant
®
(Medtronic Sofamor Danek, Inc.) , 107
Quadriceps weakness , 89, 91, 348
Quality of life (QOL) outcomes , 28

Index
361
R
Radiculopathy , 38, 53, 55, 144, 163, 183,
192, 236, 247, 290, 294
Radiographic instability , 260
®
3 (K2M, Inc.) , 108
Ravine
RAVINE retractor , 108
Recombinant human bone morphogenetic protein 2
(rh-BMP2) , 43, 190, 276
Relax retractors , 114, 122
Rhabdomyolysis , 63, 65, 193
Rifampin , 227, 228, 231
S
Safe working zone shrinks , 137
Scoliosis surgery , 24
Selective arterial embolization (SAE) , 204
Sensory dermal zones (SDZs) , 349
Shallow docking technique , 94, 139, 239
Single incision technique , 101
Small bowel obstruction , 341
Smith-Peterson osteotomy (SPO) , 265, 266
Soft tissue complication
injuries within psoas muscle corridor , 329–330
management , 333–335
preventions , 335–336
retroperitoneal injuries , 330–333
Somatosensory evoked potentials (SSEP) , 68–69
Spinal column infections , 225–226
case studies , 230–232
clinical outcomes , 228–229
complications
approach-related , 229
infection-related , 230
instrumentation-related , 230
contraindication , 227
defi nitive debridement , 226
indications , 226–227
internal fi xation , 225
technique
operative procedure , 227–228
postoperative treatment , 228
preoperative preparation , 227
tuberculosis , 225, 226
use of bone grafts , 225, 226
Spinal cord compression , 201–203, 205, 208, 209, 211
Spinal tumors
classifi cations , 201
clinical features , 202
diagnostic tools
angiography , 202
CT scan , 202
MRI , 202–203
PET , 203
plain radiographs , 202
radioisotope bone scan , 202
primary vertebral tumor , 201
aneurysmal bone cyst , 204
giant cell tumor , 205–206
hemangioma , 205
meningioma , 206–207
nerve sheath tumor , 207–208
osteosarcoma , 205
plasmacytoma and multiple myeloma , 206
surgical treatment
MIS lateral approach , 209–211
open surgery , 208–209
Spondylolisthesis , 253
complications , 160
LLIF procedure , 157
complications , 160
outcomes , 158–159
Meyerding grading system , 155, 156
preoperative lateral standing scoliosis x-ray , 155, 156
preoperative lateral x-ray , 155, 156
surgical technique , 157–158
symptoms , 155
treatment , 3, 155–157
Wiltse classifi cation , 155, 156
Spondylolithesis , 18, 53, 290
Spondylolysis , 18, 19
Spontaneous electromyography (spEMG) , 69
Spontaneous EMG (S-EMG) , 93
Stand-alone decompressive materials (X-STOP) , 248
Streptococci culture , 230
Structural iliac crest autograft bone , 227, 229
Subsidence in LLIF , 277
biomechanical data , 277
cage development , 273
classifi cation , 273–274
effect on clinical outcomes , 276
factors , 273
fusion rates , 277
prevention/recommendations , 277
rates , 274
risk factors
bone quality , 276
cage size , 276
caudal endplate , 274
levels , 276
rhBMP-2 , 276
types , 274, 275
Sugar alcohols , 343
Supplemental fi xation in LLIF , 264
benefi ts , 259
indications
algorithm , 260, 261
ASD , 260, 262
cage width and levels , 260
deformity , 260
facet arthropathy , 260
instability , 260
intraoperative vertebral endplate injury , 262
pars interarticularis defects , 260
planned section/unplanned ALL rupture , 262
previous surgery , 262
reduced bone density , 260
options
combination lateral and posterior fi xation , 263
lateral fi xation , 262
posterior fi xation , 262–263
reasons for , 259
Supra-psoas (Shallow) docking , 109
®
Surgicel
, 325

362
®
Surgifl o
, 325
SynFrame (Stratec Medical, Oberdorf, Switzerland)
retractor system , 121, 130, 210, 211
Synthetic silicate calcium phosphate (SiCap) , 43
T
Tapentadol , 343
Thigh numbness , 145, 147, 159, 160, 193, 219, 302, 330
Thoracic MIS retropleural access
advantages , 132
anterior-based approaches , 128
lateral-based approaches , 128–129
limitations , 132
open thoracotomy approach , 128
outcomes and complications , 132
posterior-based approaches , 128
surgical technique
postoperative care , 131
preoperative planning , 129
preparation and patient positioning , 129
surgical approach , 130–131
thoracoscopic approach , 128
Thoracolumbar infections , 226
Thoracolumbar-sacral-orthosis (TLSO) , 228
Thoracolumbar spinal injuries
burst fractures , 215–216
case study , 219–220
costs , 215
incidence , 215
patient challenges , 215
Thoracotomy , 23, 61, 128, 207–209, 216
Three-dimensional triangulation , 139
Tisseel , 325
TLIF . See Transforaminal lumbar interbody fusion
(TLIF)
Total intravenous anesthesia (TIVA) , 70
Total joint arthroplasty , 339
Transforaminal lumbar interbody fusion (TLIF) , 4, 18,
23, 158, 164, 247, 284
Trauma, lateral MISS in
advantages , 217, 221
anterior decompression and reconstruction ,
216, 221
disadvantages , 221
indications for anterior approach , 216
open anterior and posterior approaches
complications , 216–217
pros and cons , 218–219
techniques
corpectomy , 217
diskectomies , 217, 218
retroperitoneal approach , 217
sequential tubular dilation , 217, 218
thoracolumbar spinal injuries
burst fractures , 215–216
case study , 219–220
costs , 215
incidence , 215
patient challenges , 215
Index
β-Tricalcium phosphate (β-TCP) , 282
Triggered electromyography (t-EMG) , 69–70, 93, 267
Tubular retractor , 84, 109, 169, 302
Tumor growth factor beta (TGF-β) , 281
Two-fi nger technique , 239
Two-incision technique , 93, 176, 178, 336
U
Ultrasound , 334
V
Vascular injury , 319
anatomy of anterior and lateral region , 319–321
incidence
anterior conventional approach , 322
lateral/XLIF , 322
posterior approach , 321
management
arterial injury , 325–326
venous injury , 325
preventive measures
operative period , 323–324
postoperative period , 324–325
preoperative period , 323
retroperitoneal vessels , 326
surgical features , 322
Venous injury , 325
Venous thromboembolism , 342
®
(Baxano, Inc.) , 108–109
Ve o
VEO System , 73
Vertebroplasty , 205, 206, 208, 209
Visual analog scale (VAS) score , 28, 158, 193, 195, 211,
229, 246
W
Weakness , 32, 54, 73, 90, 137, 138, 193, 202, 219, 236,
247, 302
hip fl exion , 77, 145, 146, 159
motor , 38, 45, 160, 238
muscle , 45, 229, 329, 330, 352
postoperative psoas , 5
quadriceps , 89, 91, 348
sensory , 38, 45
X
®
. See Extreme lateral interbody fusion (XLIF ® )
XLIF
X-ray , 32, 33, 53, 56, 57, 115, 129, 144, 146, 147, 149,
156–158, 188, 196, 310, 324, 334, 336
antero-posterior , 130, 131
AP , 117, 119, 121, 122, 165, 169, 174, 175, 176
chest , 131
intraoperative , 108, 231, 232
lateral , 179, 115, 123, 165, 172, 174, 176, 273
lumbar , 283
postoperative , 58, 169, 228, 231, 232, 273
preoperative , 58, 166
Соседние файлы в папке Библиотека им академика М.И. Перельмана
